Pacing and clinical electrophysiology : PACE
-
Pacing Clin Electrophysiol · Jan 2003
Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients.
The safety of pacemaker and defibrillator implantations in orally anticoagulated patients using standard techniques has not been thoroughly evaluated. This article describes a prospectively collected experience in such patients. Patients presenting for device implantation who were treated with warfarin were allowed to continue therapy provided that the INR was < 3.5. ⋯ One patient had a small soft hematoma, which resolved spontaneously. At 6 weeks, all patients had well-healed scars with satisfactory pacing and sensing thresholds. In experienced centers, patients requiring treatment with warfarin may undergo implantation of pacemakers or defibrillators with minimal risk despite continuation of anticoagulation.
-
Pacing Clin Electrophysiol · Dec 2002
Randomized Controlled Trial Multicenter Study Clinical TrialVentricular rate stabilization for the prevention of pause dependent ventricular tachyarrhythmias: results from a prospective study in 309 ICD recipients.
Reviews of stored electrograms from ICDs revealed a 5-30% incidence of short-long-short intervals preceding the onset of recurrent ventricular tachyarrhythmias. Rate stabilization by dedicated antibradycardia pacing algorithms has, therefore, been suggested to prevent onset of pause dependent tachyarrhythmias. However, the clinical efficacy of this approach has not been studied systematically. ⋯ In an extended Cox model adjusting for confounding variables, the relative risk for recurrent episodes was 0.92 during VRS On compared to Off (95% CI: 0.58-1.48; P = 0.74). During VRS Off, pause dependent onset was documented in only 36 (8%) of 427 visually analyzed episodes. There was no significant reduction in the incidence of recurrent ventricular tachyarrhythmias with VRS On compared to the Off programming in this prospective study.
-
Pacing Clin Electrophysiol · Nov 2002
The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads.
Several investigators have shown that the incidence of venous obstruction after pacemaker implantation was observed in 31-50% of pacemaker patients. However, these previous reports did not investigate the venous system prior to implantation. The aim of this study was to determine the incidence and risk factors for venous obstruction in patients with transvenous pacing leads. ⋯ There were no significant differences between obstruction and nonobstruction groups in terms of age, sex, cardiothoracic ratio, left atrial dimension, left ventricular ejection fraction, baseline heart diseases for indication of pacemaker implantation, or number and body size of pacing leads. Neither clinical symptoms nor abnormal physical findings were observed in any patients. In conclusion, the incidence of venous obstruction after pacing lead implantation is less than that of previous reports, which might be related to the incidence of venous obstruction before pacing leads implantation.
-
Pacing Clin Electrophysiol · Oct 2002
Application of right atrial contiguous linear lesions: an in vivo efficacy validation of multipolar ablation catheters in an animal model.
Catheter ablation of atrial flutter and catheter Maze procedures require the creation of linear lesions. The efficacy of different multipolar catheters to create linear contiguous transmural lesions was studied in a sheep model. In 19 sheep a multipolar ablation catheter was inserted into the right atrium. ⋯ Microscopic endocardial fibrinous adhesions and macroscopic mild electrode carbonizations were caused by all catheter types. In conclusion, (1) all three catheter types do not create contiguous lesions along all electrodes. Gaps of viable tissue remain in most instances; (2) lesion depths and transmurality varies with different catheters; and (3) potentially hazardous thrombotic material was observed during radiofrequency ablation with all three catheters.